Evidence map›Paper›PMID 41715905›Full record

ArticleJournal of cosmetic dermatology2026

Ultrastructural Analysis of In Vitro Glycated Engineered Skin.

Kimberly Denman, Vighter Iberi, Yuri Roiter, Madison Ammon, Bin Fang, Ravi Ranatunga, Gunjan Agarwal

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kimberly DenmanDepartment of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
Vighter IberiProcter and Gamble Company, Mason, Ohio, USA.
Yuri RoiterProcter and Gamble Company, Mason, Ohio, USA.
Madison AmmonBiophysics Program, The Ohio State University, Columbus, Ohio, USA.
Bin FangProcter and Gamble Company, Mason, Ohio, USA.
Ravi RanatungaProcter and Gamble Company, Mason, Ohio, USA.
Gunjan AgarwalBiophysics Program, The Ohio State University, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0003-3731-2107

Funding

National Science Foundation 2000469
6 · The paper itself

Abstract

backgroundAging of the human skin results in undesirable physical properties such as wrinkles, yellowing, and loss of luster. Advanced glycation end-products (AGEs) are understood to be one of the primary causes for these effects as assessed from studies on human skin subjected to in vivo or in vitro mediated glycation. Models to recapitulate the effect of skin-glycation in vitro are an active area of interest to understand and mitigate these effects. In this regard, engineered skin models have utilized pre-glycated collagen to assemble a glycated skin layer. However, this method is time-consuming and can suffer from variability across samples. The objective of this study was to examine how in vitro glycation of an engineered skin model affects its material properties. MATERIALS AND

methodsIn this study we used a pre-engineered skin model (MatTek EpiDerm) and subjected it to in vitro glycation using glyceraldehyde. The changes in luminosity of the samples were characterized 48 h post-glycation. Immunohistochemistry using an anti-AGE antibody was performed to verify glycation of the samples. Scanning transmission electron microscopy (STEM) and atomic force microscopy (AFM) were used to assess the ultrastructure of the samples and evaluate their surface roughness, adhesion, and mechanical properties.

resultsOur results show that upon glycation the engineered skin had reduced luster, increased yellowing, disruption in cell and matrix morphology, increased roughness, and modulus. These effects are similar to those previously reported in both natural and engineered skin.

conclusionsOverall, the approach presented here serves as a quick and easy method to recapitulate the glycation induced effects in the model skin and can serve as a platform to evaluate the effect of skin-care products on mitigating these effects.

Indexed as

Glycation End Products, AdvancedSkinSkin AgingSkin, ArtificialTissue EngineeringGlycosylationHumansMicroscopy, Atomic ForceMicroscopy, Electron, ScanningSurface PropertiesGlycation End Products, Advancedatomic force microscopyglycationmechanicsscanning transmission electron microscopyskin

Identifiers

PMID41715905
PMCPMC12921346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.